Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
55%(6 trials)

Phase Distribution

Ph phase_3
3
27%
Ph phase_4
8
73%

Phase Distribution

0

Early Stage

0

Mid Stage

11

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
3(27.3%)
Phase 4Post-market surveillance
8(72.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(11)

Detailed Status

Completed11

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (27.3%)
Phase 48 (72.7%)

Trials by Status

completed11100%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11